Picture of Venture Life logo

VLG — Venture Life Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+0.74%
3m-2.52%
6m+21.19%
1yr-62.01%
Volume Change (%)
10d/3m-70.28%
Price vs... (%)
52w High-67.16%
50d MA-5.58%
200d MA-20.35%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)8.19
PEG Ratio (f)0.32
EPS Growth (f)34.32%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.58
Price to Tang. Book5.24
Price to Free Cashflown/a
Price to Sales1.29
EV to EBITDA9.83

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital1.47%
Return on Equity3.31%
Operating Margin4.18%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue£m16.0518.7720.2130.0832.7640.9145.6318.07%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/a+109.71+155.32-20.19+56.19+20.4n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for VLG

Venture Life (LON:VLG): buy, sell or hold? background image

Venture Life (LON:VLG): buy, sell or hold?

Shares in Venture Life (LON:VLG) are currently trading close to a 52 week high, with the share price up by around 9.68% - to 102 - over the past week. On a one-month basis, the Venture Life share price has risen by 2.00%. For investors...

Venture Life hits 52w high – but will it continue? background image

Venture Life hits 52w high – but will it continue?

It's a good time to be a shareholder in Venture Life (LON:VLG): as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. Shares in Venture Life are curren...

Venture Life (LON:VLG): buy, sell or hold? background image

Venture Life (LON:VLG): buy, sell or hold?

Shares in Venture Life (LON:VLG) are currently trading close to a 52 week high, with the share price up by around 17.0% - to 102.5 - over the past week. On a one-month basis, the Venture Life share price has risen by 10.2%. For investo...

Venture Life (LON:VLG): buy, sell or hold? background image

Venture Life (LON:VLG): buy, sell or hold?

Shares in Venture Life (LON:VLG) are currently trading close to a 52 week high, with the share price up by around 4.92% - to 96.72 - over the past week. On a one-month basis, the Venture Life share price has risen by 20.0%. For investo...

Venture Life (LON:VLG) price about to hit new 52-week high background image

Venture Life (LON:VLG) price about to hit new 52-week high

The good news for any holders of Venture Life (LON:VLG) is that the price is currently trading close to a 52 week high, with the share price up by around 10.7% to 86.551 over the past week.  For investors holding the stock (or consider...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Venture Life EPS forecast chart

Profile Summary

Venture Life Group plc is a United Kingdom-based consumer self-care company. The Company is focused on developing, manufacturing and commercializing products for the global self-care market. The Company's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
December 12th, 2005
Public Since
March 28th, 2014
No. of Employees
145
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
126,498,197

VLG Share Price Performance

Latest News for VLG

Upcoming Events for VLG

Half Year 2022 Venture Life Group PLC Earnings Release

Similar to VLG

Picture of Abcam logo

Abcam

gb flag iconLondon Stock Exchange

Picture of Alliance Pharma logo

Alliance Pharma

gb flag iconLondon Stock Exchange

Picture of Animalcare logo

Animalcare

gb flag iconLondon Stock Exchange

Picture of AstraZeneca logo

AstraZeneca

gb flag iconLondon Stock Exchange

Picture of Benchmark Holdings logo

Benchmark Holdings

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email